Bizzarri, F.; Ruiz-Villaverde, R.; Morales-Garrido, P.; Ruiz-Carrascosa, J.C.; Cebolla-Verdugo, M.; Prados-Carmona, A.; Rodriguez-Troncoso, M.; Raya-Alvarez, E.
JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice. Diagnostics 2024, 14, 988.
https://doi.org/10.3390/diagnostics14100988
AMA Style
Bizzarri F, Ruiz-Villaverde R, Morales-Garrido P, Ruiz-Carrascosa JC, Cebolla-Verdugo M, Prados-Carmona A, Rodriguez-Troncoso M, Raya-Alvarez E.
JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice. Diagnostics. 2024; 14(10):988.
https://doi.org/10.3390/diagnostics14100988
Chicago/Turabian Style
Bizzarri, Francesco, Ricardo Ruiz-Villaverde, Pilar Morales-Garrido, Jose Carlos Ruiz-Carrascosa, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, Mar Rodriguez-Troncoso, and Enrique Raya-Alvarez.
2024. "JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice" Diagnostics 14, no. 10: 988.
https://doi.org/10.3390/diagnostics14100988
APA Style
Bizzarri, F., Ruiz-Villaverde, R., Morales-Garrido, P., Ruiz-Carrascosa, J. C., Cebolla-Verdugo, M., Prados-Carmona, A., Rodriguez-Troncoso, M., & Raya-Alvarez, E.
(2024). JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice. Diagnostics, 14(10), 988.
https://doi.org/10.3390/diagnostics14100988
